In California, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, used the gene-editing tool, CRISPR, to reprogram mutated rod photoreceptors and restoring vision in two mouse models. Retinitis pigmentosa is an inherited vision disorder resulting from genetic mutation in more than 60 genes making it difficult for night vision, peripheral vision, color discernment and central vision. It affects about 1 in 4,000 people globally with the eventual result possibly becoming legal blindness and there is no current treatment for it. The ability of researchers to shut off or deactivate certain gene “switches” allowed them to modify select genes to restore vision. They hope to perform clinical trials on humans soon since there is no other treatment or cure for retinitis pigmentosa currently.
Latest article
Data boom to data shroom: Mycelium could one day be data storage
In Ohio, scientists at Ohio State University have shown that mushroom mycelium can act as a form of data storage. In controlled lab experiments,...
Wooden compass points dementia patients back home
In the Netherlands, a startup has unveiled a device for dementia patients that is comprised of a single arrow that points to only one...
Snack to the future: Nutri3D wants to 3D print your next sweet treat
In Italy, researchers in the Nutri3D project have unveiled prototypes of nutrient-rich sweet snacks made from cultured plant cells, fruit byproducts, and 3D printing....